Zhejiang Cancer Hospital

This study looks at people with advanced HER2-positive breast cancer whose first treatment stops working. It compares two different targeted therapy combinations to see which works better when switched. About 600 participants will be followed to track how long the cancer stays co…

This study tests a new drug combination (distamab vedotin plus carboplatin) in 20 people with advanced ovarian cancer that has a specific protein called HER2. The goal is to see if this combo works better and causes fewer side effects than the usual chemotherapy. Participants mus…

This study tests a chemotherapy combination (albumin-bound paclitaxel and nedaplatin) given directly into the liver artery for breast cancer patients whose disease has spread only to the liver and who have not responded to standard treatments. The goal is to control liver tumors …

This study tests a two-step treatment for adults with early-stage MALT lymphoma: a very low dose of radiation (4 Gy total) followed by a daily targeted pill (orelabrutinib) for up to 6 months. The goal is to control the cancer while avoiding harsh side effects like dry mouth or c…

This study tests whether a single infusion of umbilical cord blood can safely raise platelet levels in cancer patients whose platelet counts have dropped due to chemotherapy or other cancer treatments. Researchers will enroll 25 people aged 12 to 65 and monitor their blood counts…

This study tests whether adding the drugs entinostat and anlotinib to the standard hormone therapy fulvestrant can shrink tumors or slow cancer growth in people with advanced HR+/HER2- breast cancer that has worsened after prior treatments. About 118 women aged 18 and older will …

This study tests a combination of three drugs (thiotepa, pirtobrutinib, and sintilimab) in 24 adults with a type of brain lymphoma that has returned or is hard to treat. The goal is to see if the treatment can shrink or control the cancer. Participants may also receive a stem cel…

This study tests whether adding the experimental drug IBI363 to standard chemotherapy can better shrink or eliminate stomach cancer before surgery. It includes 60 adults with a specific type of advanced stomach cancer that lacks a certain immune marker. The goal is to see if this…

This study looks at how American ginseng changes the body's chemistry in healthy adults. Twenty people will take 3 grams of ginseng powder daily for 14 days. Researchers will collect urine and blood samples to measure metabolic changes. The goal is to understand ginseng's effects…